MODECATE Side Effects

5984135-8 | Injection Site Cyst, Injection Site Fibrosis, Injection Site Necrosis, Migraine
on Dec 03, 2008 Female patient from FRANCE , 46 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?), migraine (What is migraine?), insomnia, anxiety (What is anxiety?), pain (What is pain?), constipation (What is constipation?) and was treated with Modecate (View Usage). Patient experienced the following unwanted or unexpected effects: injection site cyst, injection site fibrosis, injection site necrosis, migraine (What is migraine?). Modecate dosage: Form = Solution, Strength 125mg, Duration: 16week5day.. During the same period patient was treated with SEGLOR (Formulation: Capsule, Strength:5mg) (View Seglor Review and Seglor Label ), NARAMIG (View Naramig Review and Naramig Label ), IMOVANE (1 Df= 1unit) (View Imovane Review and Imovane Label ), LEPTICUR (View Lepticur Review and Lepticur Label ), NOZINAN (View Nozinan Review and Nozinan Label ), DI ANTALVIC (1 Dosage Form = 6 Unit) (View Di-antalvic Review and Di-antalvic Label ), TRANSIPEG (View Transipeg Review and Transipeg Label ). Patient was hospitalized.

5908322-X | Injection Site Cyst, Injection Site Fibrosis, Injection Site Necrosis
Patient was taking Modecate (View Usage). Patient had the following side effects: injection site cyst, injection site fibrosis, injection site necrosis on Sep 30, 2008 from FRANCE Additional patient health information: Female patient , 46 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?), migraine (What is migraine?), insomnia, anxiety (What is anxiety?), pain (What is pain?), constipation (What is constipation?) and. Modecate dosage: Form = Solution, Strength 125mg, Duration: 16week5day.. During the same period patient was treated with SEGLOR (Formulation: Capsule, Strength:5mg) (View Seglor Review and Seglor Label ), NARAMIG (View Naramig Review and Naramig Label ), IMOVANE (1 Df= 1unit) (View Imovane Review and Imovane Label ), LEPTICUR (View Lepticur Review and Lepticur Label ), NOZINAN (View Nozinan Review and Nozinan Label ), PROPOXYPHENE HCL AND ACETAMINOPHEN (1 Dosage Form = 6 Unit) (View Propoxyphene Hcl And Acetaminophen Review and Propoxyphene Hcl And Acetaminophen Label ), TRANSIPEG (View Transipeg Review and Transipeg Label ). Patient was hospitalized.

5852314-6 | Injection Site Necrosis
Adverse event was reported on Aug 18, 2008 by a Female patient taking Modecate (View Usage) (Dosage: Form = Solution) . Location: FRANCE , 46 years of age, After Modecate was administered, patient had the following side effects: injection site necrosis. During the same period patient was treated with SEGLOR (View Seglor Review and Seglor Label ), NARAMIG (View Naramig Review and Naramig Label ).

5608789-0 | Cerebral Infarction, Tachyarrhythmia
on Jan 28, 2008 Female patient from UNITED KINGDOM , 66 years of age, was diagnosed with schizophrenia and was treated with Modecate (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction, tachyarrhythmia. Modecate dosage: Started 20 Years Ago.. During the same period patient was treated with NEULACTIL (View Neulactil Review and Neulactil Label ).


5129449-9 | Dehydration, Depressed Level Of Consciousness, Urinary Retention
on May 29, 2006 Female patient from FRANCE , 75 years of age, was diagnosed with agitation, depression (What is depression?) and was treated with Modecate (View Usage). Patient had the following side effects: dehydration, depressed level of consciousness, urinary retention. Modecate dosage: . During the same period patient was treated with ARTANE (View Artane Review and Artane Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ). Patient was hospitalized.

5021427-3 | Dehydration, Depressed Level Of Consciousness, Oligodipsia, Urinary Retention
Patient was taking Modecate (View Usage). After Modecate was administered, patient had the following side effects: dehydration, depressed level of consciousness, oligodipsia, urinary retention on May 29, 2006 from FRANCE Additional patient health information: Female patient , 75 years of age, was diagnosed with agitation, depressed mood and. Modecate dosage: . During the same period patient was treated with ARTANE (View Artane Review and Artane Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

4968339-9 | Asthenia, Central Pontine Myelinolysis, Coma, Hyponatraemia, Vomiting
Adverse event was reported on Jun 25, 2002 by a Female patient taking Modecate (View Usage) (Dosage: Date Stated: Long-term) was diagnosed with schizophreniform disorder, essential hypertension and. Location: SPAIN , 55 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, central pontine myelinolysis, coma, hyponatraemia, vomiting. During the same period patient was treated with MODURETIC 5 50 (5/50 Mg) (View Moduretic 5-50 Review and Moduretic 5-50 Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), TRANXILIUM (Date Stated: Long-term) (View Tranxilium Review and Tranxilium Label ). Patient was hospitalized.

4948357-7 | Multiple Fractures, Suicide Attempt
on Mar 09, 2006 Male patient from UNITED KINGDOM , 48 years of age, was diagnosed with bipolar i disorder and was treated with Modecate (View Usage). Patient had the following side effects: multiple fractures, suicide attempt. Modecate dosage: . Patient was hospitalized.

4864479-3 | Circulatory Collapse, Hypotension, Urinary Tract Infection
on Aug 30, 2005 Female patient from AUSTRALIA , 81 years of age, was treated with Modecate (View Usage). After Modecate was administered, patient had the following side effects: circulatory collapse, hypotension, urinary tract infection (What is urinary tract infection?). Modecate dosage: . During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ).

4864475-6 | Neuroleptic Malignant Syndrome, Pyrexia, Renal Failure Acute, Rhabdomyolysis
Patient was taking Modecate (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome, pyrexia, renal failure acute, rhabdomyolysis on Aug 29, 2005 from FRANCE Additional patient health information: Female patient , 42 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?), diabetes mellitus and. Modecate dosage: . During the same period patient was treated with TERCIAN (View Tercian Review and Tercian Label ), LOXAPAC (View Loxapac Review and Loxapac Label ), AVANDAMET (View Avandamet Review and Avandamet Label ), AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

4864455-0 | Hyperthyroidism
Adverse event was reported on Feb 22, 2005 by a Male patient taking Modecate (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 56 years of age, Patient had the following side effects: hyperthyroidism. During the same period patient was treated with CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ).

4664994-1 | Hyperkalaemia, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion, Pneumonia
on Nov 25, 2004 Male patient from , 32 years of age, was diagnosed with hypertrophic cardiomyopathy and was treated with Modecate (View Usage). After Modecate was administered, patient had the following side effects: hyperkalaemia, hyponatraemia, inappropriate antidiuretic hormone secretion, pneumonia (What is pneumonia?). Modecate dosage: . During the same period patient was treated with MEPRONIZINE (Duration: Several Months) (View Mepronizine Review and Mepronizine Label ), VICTAN (View Victan Review and Victan Label ), STILNOX (View Stilnox Review and Stilnox Label ), DEPAKENE (View Depakene Review and Depakene Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), ZYLORIC (View Zyloric Review and Zyloric Label ). Patient was hospitalized.